33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MERMAID-2: Phase III study of durvalumab in patients with resected, stage II-III NSCLC who become MRD+ after curative-intent therapy
    Meeting Abstract

    Spigel, D. R.; Peters, S.; Ahn, M. J.; Tsuboi, M.; Chaft, J.; Harpole, D.; Barlesi, F.; Abbosh, C.; Mann, H.; May, R.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 2 study of zenocutuzumab (MCLA-128), a bispecific HER2/HER3 antibody in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A.; Macarulla, T.; O'Reilly, E.; Rodon, J.; Wolpin, B.; Ou, S.; Kim, D.; Yang, J. C.; Lam, J.; De Langen, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Activity of tepotinib in brain metastases (BM): Preclinical and clinical data in MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Felip, E.; Le, X.; Garassino, M. C.; Stanton, T.; Morise, M.; Lee, J.; Matsumoto, S.; De Marinis, F.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations
    Meeting Abstract

    Pant, S.; Tabernero, J.; Massard, C.; Hyman, D. M.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • 3D analysis of spread through air spaces in squamous cell carcinoma and carcinoid tumor using whole block imaging by micro CT
    Meeting Abstract

    Inoue, T.; Teplov, A.; Rekhtman, N.; Chida, M.; Travis, W.; Yagi, Y.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Computer extracted morphology features of tumor nuclei predict response to chemotherapy and prognostic of OS in small cell lung cancer
    Meeting Abstract

    Jain, P.; Barrera, C.; Osme, A.; Toro, P. A.; Chahar, S.; Butler, K.; Khorrami, M.; Fu, P.; Corredor, G.; Bera, K.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Delta-radiomics features for assessment of individualized therapeutic response in small cell lung cancer - A pilot study
    Meeting Abstract

    Araujo Filho, J.; Murciano-Goroff, Y.; Gibbs, P.; Perez-Johnston, R.; Lai, W. V.; Rudin, C.; Li, B.; Ginsberg, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • ORCHARD: A biomarker-directed phase 2 platform study in pts with advanced EGFRm NSCLC progressing on first-line osimertinib
    Meeting Abstract

    Cho, B. C.; Piotrowska, Z.; Le, X.; Goldberg, S. B.; Goldman, J.; De Langen, A.; Okamoto, I.; Smith, P.; Mensi, I.; Maidment, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • TIP: Romiplostim for chemo-induced thrombocytopenia in adults with solid tumors; A P3 randomized placebo-controlled double-blind studies
    Meeting Abstract

    Armas, A.; Soff, G.; Camargo, J.; Bunn, P. Jr; Munoz, C.; Kuter, D.; Scotte, F.; Park, J.; Bowers, C.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CD8α-enhanced NY-ESO-1-specific TCR T Cells (GSK3901961) in HLA-A*02 patients with NSCLC: Master protocol substudy 1
    Meeting Abstract

    Altan, M.; Govindan, R.; Schoenfeld, A.; Noujaim, J.; Sacher, A.; Haanen, J.; Huang, C.; Hasan, A.; Faitg, T.; Butler, E.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save